Retinal Consultants of Southern California logo for print

Address: 1220 La Venta Drive
Suite 211
Westlake Village, California 91361
Telephone: (805) 379-0200
Fax: (805) 496-5204

Retinal Consultants of Southern California Logo

  Patient Registration

Related Links

Clinical Research

  • Branch Vein Occlusion Study
  • Diabetic Retinopathy Vitrectomy Study
  • Early Treatment of Diabetic Retinopathy Study
  • Silicone Oil Study
  • Prophylactic Treatment of Age Related Macular Degeneration Study
  • Diode Laser for Melanocytic Lesion Study
  • Collaborative Ocular Melanoma Study
  • SAILOR Study of Lucentis for Age Related Macular Degeneration
  • AREDS II for Age Related Macular Degeneration
  • Diabetic Retinopathy Clinical Research Network Protocol N: An Evaluation of Intravitreal Hemorrhage Due to Proliferative Diabetic Retinopathy
  • VGFT-OD-0910: An Open Label, Long-Term, Safety and Tolerability Extension Study of Intravitreal VEGF Trap-Eye in Neovascular Age Related Macular Degeneration
  • HARBOR Study: DNA Repository Substudy in Association with Ranibizumab Study FVF4579g: A Phase 3, Double-Masked Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Safety of 0.5-mg and 2.0-mg Ranibizumab Administered monthly or on an as needed basis (prn) with a Safety run-in of a Single Dose of a 2.0-mg Ranibizumab in Patients with a Sub Foveal Neovascular Age Related Macular Degeneration
  • VGFT-OD-0702: An Open Label, Long Term, Safety and Tolerability Study of Intravitreal VEGF-Trap in Subjects with a Neovascular Age Related Macular Degeneration
  • Protocol FVF4170gRISE: A Phase 3, Double-Masked, Multicenter, Randomized, Sham-Controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus
  • Diabetic Retinopathy Clinical Research Network Protocol R:  A Phase II Evaluation of Topical NSAIDs in Eyes with Non-central Involved DME
  • Diabetic Retinopathy Clinical Research Network Protocol T:  A Comparative Effectiveness  Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema

We are currently participating in the following clinical trials:

  • Diabetic Retinopathy Clinical Research Network Protocol V:  Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity
  • Diabetic Retinopathy Clinical Research Network Protocol AA:  Peripheral DR Lesions on Ultrawide-field Fundus Images and Risk of Diabetic Retinopathy Worsening Over Time
  • Diabetic Retinopathy Clinical Research Network Protocol Genetics:  Genes in Diabetic Retinopathy Project